Arzerra (Ofatumumab) 1000mg/50ml

Ofatumumab 1000mg/50ml injection is a prescription therapy designed for certain blood disorders. It is administered under medical supervision to support immune system regulation. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using this medication.

Strength

1000mg/50ml

Pack Size

Storage

2-8ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ofatumumab is used to treat specific types of blood cancers, including chronic lymphocytic leukemia and follicular lymphoma. It works by targeting immune cells to reduce disease progression. Patients often ask, 'what is Ofatumumab used for' when exploring treatment options for these conditions. This therapy is typically prescribed when other treatments have not been effective.

Side Effects

Common effects include infusion-related reactions such as fever, chills, or fatigue during administration. Some patients may experience nausea or headache afterward. These effects are generally temporary and monitored closely by healthcare professionals.

Precautions & Warnings

Keep the medication refrigerated between 2-8°C and protect it from light. Do not freeze or shake the vial. Always handle with care to avoid contamination. Discuss any pre-existing conditions with your healthcare provider before starting treatment.

Avoid Interactions

Certain medications, including vaccines and immunosuppressants, may interact with Ofatumumab. Avoid live vaccines during treatment unless approved by a doctor. Inform your healthcare provider about all prescription and over-the-counter medications you are taking.

Frequently Asked Questions

Ofatumumab is prescribed for certain blood cancers like chronic lymphocytic leukemia and follicular lymphoma.

It is given as an intravenous infusion under medical supervision, typically in a clinical setting.

Infusion-related reactions such as fever, chills, or fatigue are commonly reported during administration.

No, it must be refrigerated between 2-8°C and protected from light to maintain efficacy.

Yes, it may interact with vaccines and immunosuppressants; always inform your doctor about all medications you take.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.